The clinical research of cell-broken decoction pieces of danggui buxue decoction in the treatment of blood deficiency syndrome

As compared with traditional decoction pieces of danggui buxue decoction, methods a multicenter, randomized, single-blind, parallel design, to evaluate the safety and efficacy of different dose of cell-broken decoction pieces of danggui buxue decoction in treatment of blood deficiency syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800015600

Enrollment

Unknown

Registered

2018-04-11

Start date

2018-05-02

Completion date

Unknown

Last updated

2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blood deficiency syndrome

Interventions

Traditional Chinese Medicine decoction pieces group:traditional decoction pieces of danggui buxue decoction

traditional dose of cell-broken decoction pieces group:cell-broken decoction pieces of danggui buxue decoction

1/3 dose of cell-broken decoction pieces group:cell-broken decoction pieces of danggui buxue decoction

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18 to 75 years old; (2) Fulfill the TCM diagnosed of blood deficiency syndrome; (3) Patients were required to have mild to moderate anemia(60g/L<MCHC<minimum level; male: 120g/L, female: 110g/L) prior to study enrollment; (4) Patients who sign the informed consent form freely and voluntarily.

Exclusion criteria

Exclusion criteria: (1) Patients who have acute anemia which result from trauma,acute hemorrhagic disease or other disease; (2) Patients who have severe diseases of blood system; (3) Combined with severity serious disease, for example, the liver function (ALT,AST) exceeding 1.5 times than normal limit, the kidney function (Cr) exceeding the normal limit; (4) Participating in other clinical trial, or participated in any other clinical treatment within 30 days prior to screening; (5) Lactating or pregnant women,planning for pregnancy; (6) The researchers consider that, the patients are not suitable.

Design outcomes

Primary

Measure	Time frame
TCM syndrome;	—

Secondary

Measure	Time frame
curative effect of anemia;the disappearingrate of symptomsandsigns;	—

Countries

China

Contacts

Public ContactChen Pei

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

chenpei3020@sina.com+86 021-53825737

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026